235 related articles for article (PubMed ID: 32375515)
21. Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT.
Furuhashi N; Suzuki K; Sakurai Y; Ikeda M; Kawai Y; Naganawa S
Eur Radiol; 2015 May; 25(5):1366-74. PubMed ID: 25433412
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS
Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300
[TBL] [Abstract][Full Text] [Related]
23. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
[TBL] [Abstract][Full Text] [Related]
25. Machine Learning Methods Based on CT Features Differentiate G1/G2 From G3 Pancreatic Neuroendocrine Tumors.
Chen HY; Pan Y; Chen JY; Chen J; Liu LL; Yang YB; Li K; Ma Q; Shi L; Yu RS; Shao GL
Acad Radiol; 2024 May; 31(5):1898-1905. PubMed ID: 38052672
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour.
Kim DW; Kim HJ; Kim KW; Byun JH; Song KB; Kim JH; Hong SM
Eur Radiol; 2015 May; 25(5):1375-83. PubMed ID: 25465713
[TBL] [Abstract][Full Text] [Related]
27. Differentiation between solid pseudopapillary neoplasm of the pancreas and hypovascular pancreatic neuroendocrine tumors by using computed tomography.
Wang C; Cui W; Wang J; Chen X; Tong H; Wang Z
Acta Radiol; 2019 Oct; 60(10):1216-1223. PubMed ID: 30678482
[No Abstract] [Full Text] [Related]
28. Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer.
Sun GF; Zuo CJ; Shao CW; Wang JH; Zhang J
World J Gastroenterol; 2013 Jun; 19(23):3634-41. PubMed ID: 23801866
[TBL] [Abstract][Full Text] [Related]
29. Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography.
Yamada S; Fujii T; Suzuki K; Inokawa Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2016 Feb; 45(2):198-203. PubMed ID: 26390421
[TBL] [Abstract][Full Text] [Related]
30. Distinguishing pancreatic solid serous cystadenomas from nonfunctional pancreatic neuroendocrine tumors by computed tomography: A propensity score analysis.
Fang X; Jiang H; Cao K; Li J; Liu F; Wang L; Lu J; Shao C; Bian Y
Medicine (Baltimore); 2022 Sep; 101(37):e30523. PubMed ID: 36123910
[TBL] [Abstract][Full Text] [Related]
31. Multiple solid pancreatic lesions: Prevalence and features of non-malignancies on dynamic enhanced CT.
Zhu L; Dai MH; Wang ST; Jin ZY; Wang Q; Denecke T; Hamm B; Xue HD
Eur J Radiol; 2018 Aug; 105():8-14. PubMed ID: 30017302
[TBL] [Abstract][Full Text] [Related]
32. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
[No Abstract] [Full Text] [Related]
33. Pancreatic neuroendocrine tumors: MR imaging features preoperatively predict lymph node metastasis.
Sun H; Zhou J; Liu K; Shen T; Wang X; Wang X
Abdom Radiol (NY); 2019 Mar; 44(3):1000-1009. PubMed ID: 30539251
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance.
Lee NJ; Hruban RH; Fishman EK
Abdom Radiol (NY); 2018 Nov; 43(11):3025-3034. PubMed ID: 29594467
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis.
Choi TW; Kim JH; Yu MH; Park SJ; Han JK
Acta Radiol; 2018 Apr; 59(4):383-392. PubMed ID: 28766979
[TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis of solid pancreatic lesions using contrast-enhanced three-dimensional ultrasonography.
Miwa H; Numata K; Sugimori K; Kaneko T; Sakamaki K; Ueda M; Fukuda H; Tanaka K; Maeda S
Abdom Imaging; 2014 Oct; 39(5):988-99. PubMed ID: 24711063
[TBL] [Abstract][Full Text] [Related]
37. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter N
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):310-8. PubMed ID: 25265251
[TBL] [Abstract][Full Text] [Related]
38. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
39. Hypervascular lesions of the pancreas: Think before you act.
Wcislak SM; Stiles ZE; Deneve JL; Glazer ES; Behrman SW; Farooq FT; Dickson PV
Am J Surg; 2019 Aug; 218(2):362-367. PubMed ID: 30509457
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades.
Salahshour F; Mehrabinejad MM; Zare Dehnavi A; Alibakhshi A; Dashti H; Ataee MA; Ayoobi Yazdi N
Abdom Radiol (NY); 2020 Oct; 45(10):3155-3162. PubMed ID: 31897681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
